"Special delivery" to cancer cells.
Fefer
Alexander
A
University of Washington, USA.
D000818:Animals; D000912:Antibodies, Neoplasm / Q000008:administration & dosage / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D016503:Drug Delivery Systems / Q000379:methods*; D005109:Extracellular Matrix / Q000276:immunology; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage*; D009369:Neoplasms / Q000188:drug therapy / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000276:immunology / Q000473:pathology; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage / Q000627:therapeutic use
D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D007376:Interleukin-2; D011993:Recombinant Fusion Proteins